These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11769084)

  • 1. [Fundamental bases of urothelial carcinogenesis].
    Chopin D; Cappellen D; Fradvanyi F; Gattegno B
    Prog Urol; 2001 Nov; 11(5):879-924. PubMed ID: 11769084
    [No Abstract]   [Full Text] [Related]  

  • 2. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.
    Painter DJ; Timoney AG; Denton K; Alken P; Keeley FX
    BJU Int; 2007 May; 99(5):973-7. PubMed ID: 17437428
    [No Abstract]   [Full Text] [Related]  

  • 3. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.
    Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L
    Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology].
    Seisen T; Cancel-Tassin G; Colin P; Cussenot O; Rouprêt M
    Prog Urol; 2014 Nov; 24(15):943-53. PubMed ID: 25158326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erdafitinib for advanced urothelial carcinoma.
    Burki TK
    Lancet Oncol; 2019 Sep; 20(9):e469. PubMed ID: 31378458
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular Pathology of Urothelial Carcinoma.
    Al-Ahmadie H; Netto GJ
    Clin Lab Med; 2024 Jun; 44(2):181-198. PubMed ID: 38821640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability.
    Hartmann A; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Blaszyk H
    Hum Pathol; 2003 Mar; 34(3):222-7. PubMed ID: 12673555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urothelial carcinomas of the upper tract: the myth became a reality].
    Rouprêt M; Colin P
    Prog Urol; 2014 Nov; 24(15):939-42. PubMed ID: 25195030
    [No Abstract]   [Full Text] [Related]  

  • 10. Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation.
    Ali SM; Miller VA; Ross JS; Pal SK
    Eur Urol; 2015 Jun; 67(6):1195-1196. PubMed ID: 25630452
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micropapillary urothelial carcinoma of the urinary tract.
    Humphrey PA
    J Urol; 2011 Sep; 186(3):1071-2. PubMed ID: 21784465
    [No Abstract]   [Full Text] [Related]  

  • 13. Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial Cancer.
    Chang WS; Liao CH; Hsu CM; Huang CY; Fang HY; Kao PY; Tsai CW; Wu HC; Hu PS; Wang TC; Syu YR; Shui HA; Bau DT
    Anticancer Res; 2015 May; 35(5):2725-30. PubMed ID: 25964551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mouse urothelial cell lines in different phases of transitional-cell carcinogenesis.
    De Boer WI; Rebel JM; Foekens JA; Vermey M; Van der Kwast TH
    Int J Cancer; 1993 Jul; 54(6):1022-7. PubMed ID: 7687588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
    Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
    J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma.
    Inoue T; Sato K; Tsuchiya N; Matsuura S; Iinuma M; Habuchi T; Kato T
    Urology; 2004 Sep; 64(3):617-21. PubMed ID: 15351620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Mongiat-Artus P
    Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
    [No Abstract]   [Full Text] [Related]  

  • 18. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance of HER2 expression in primary and recurrent/metastatic urothelial carcinoma in the upper tract.
    Ye J; Zhang M; Bao Y
    Asian J Surg; 2024 Sep; 47(9):3928-3929. PubMed ID: 38744655
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T
    Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.